NORTHWEST BIOTHERAPEUTICS INC (NWBO) Net margin 2016–2025
NORTHWEST BIOTHERAPEUTICS INC (NWBO) net profit margin by fiscal year — reported net income divided by reported revenue.
-4365.9%FY2025 · since FY2016: -12875.4% → -4365.9%
| Fiscal year | Value | YoY |
|---|---|---|
| FY2025 | -4365.9% | +1696.2 pp |
| FY2024 | -6062.1% | -2822.0 pp |
| FY2023 | -3240.1% | +3000.6 pp |
| FY2022 | -6240.8% | -24064.2 pp |
| FY2021 | 17823.5% | +58863.1 pp |
| FY2020 | -41039.6% | -40176.0 pp |
| FY2019 | -863.6% | +7824.3 pp |
| FY2018 | -8687.9% | +13080.9 pp |
| FY2017 | -21768.7% | -8893.3 pp |
| FY2016 | -12875.4% | — |
Net margin = reported net income ÷ reported revenue for the same fiscal year. Loss years show as a negative margin.
Source: SEC XBRL filings · For reference only · Not investment advice
More NWBO financial trends
NWBO RevenueNWBO Net incomeNWBO Gross profitNWBO Gross marginNWBO Operating incomeNWBO Operating marginNWBO Operating cash flowNWBO Free cash flowNWBO Capital expendituresNWBO Return on equityNWBO Stock buybacksNWBO Dividends paidNWBO Total assetsNWBO Total liabilitiesNWBO Shareholders’ equityNWBO overview →